Share the Video:

Updates from leading statewide regulatory initiatives - Colorado

Rev Veronica Lightning Horse P…, Ean Seeb, Hadas Alterman

The last few years have seen the first successful statewide initiatives to regulate the adult use of psychedelic substances in the country: Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act. While eleven other states so far in 2023 consider their own drug policy reforms, many are watching these programs closely. Join us to hear from leaders navigating the challenges of implementing these unprecedented initiatives.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Updates from leading statewide regulatory initiatives - Oregon

Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use, influencing drug policy reforms in eleven other states in 2023.

Angela E Albee, Sam Chapman

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Research and Science

The Opportunities and Challenges for New Psychedelic Researchers to Receive NIH Funding — Heffter Research Institute and International Society for Research on Psychedelics

Heffter Research Institute funds classic psychedelic drug research. Panel advocates for increased funding by Congressional Psychedelics Advancing Clinical Treatments Caucus, emphasizing support for new researchers and ongoing discoveries.

George Greer, Steven Grant, Katrin H. Preller

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Visionary approaches: psychedelic policy in a global context

International drug policy, historically mirroring US prohibitionist approach, is evolving. Leaders propose regulatory solutions in context of broader drug reform for unified post-prohibition world.

Steve Rolles, Kasia Malinowska

PS2023 Policy Policy and Advocacy Psychedelic Science Research Research and Science Social and Cultural

Psychedelic policy approaches: from the visionary to the pragmatic

Discussion between experts on pragmatic frameworks, demographic considerations, and evidence-based practices shaping psychedelic policy reform for diverse contexts, addressing regulatory challenges and fostering nuanced understanding.

Tatiana Quintana, Melissa Lavasani, Logan Davidson

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Building momentum for new state policy approaches

Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.

Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Research and Science

What Will People Think? Revealing Public Knowledge, Belief, and Perceptions of Psychedelics

Imran Khan presents findings of the Psychedelic Insight Poll, a national survey by the Berkeley Center for the Science of Psychedelics to understand public perceptions of psychedelic substances. The poll

Imran Khan

PS2023 Policy and Advocacy Psychedelic Science Psychedelic-AT Public Benefit Research

Visionary Women: Transforming Psychedelic Medicine

Vicky Dulai of Compassion For Addiction moderates a discussion with Amy Emerson of MAPS Public Benefit Corporation and Rachel Yehuda of Icahn School of Medicine on leadership in the psychedelic

Rachel Yehuda

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Designing a post-prohibition future

Harms of drug prohibition include trauma and research prevention. Policies should shift focus from criminalizing psychedelics to supporting safe, beneficial use, fostering an imaginative world for future generations.

Ariel Clark, Christopher Medina-Kirchner, Roman Haferd, Betty Aldworth, Paula Graciela Kahn

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies

TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.

Jeannie Moller Fontana

Updates from leading statewide regulatory initiatives - Colorado

Become a MAPS Member with a monthly donation

Related Videos